BACKGROUND: The formation of the cornified cell envelope (CE) during the late stages of epidermal differentiation is essential for epidermal barrier function and protects the body against environmental attack and water loss. Formation of the CE involves the replacement of the plasma membrane by cross-linkage of precursor proteins such as involucrin, small proline rich proteins (SPRR) and loricrin. In normal epidermis, SPRR1 is restricted to appendages, SPRR2 is also expressed in interfollicular areas, while SPRR3 is completely absent; the latter is most abundant in oral epithelium. This differential expression indicates an important part for SPRRs in specific barrier requirements, and reflects their importance in the biomechanical properties of the CE. OBJECTIVES: We report here on the expression of SPRR1, SPRR2 and SPRR3 in a wide range of cutaneous neoplastic and inflammatory diseases. METHODS: We used immunohistochemistry; in addition, Northern blot analysis of malignant tumours was performed. RESULTS: Increased suprabasal expression of SPRR1 and SPRR2, but no SPRR3 expression, was noted in inflammatory dermatoses with orthokeratotic and parakeratotic squamous differentiation. By contrast, differentiating epidermal tumours such as Bowen's disease, keratoacanthoma and squamous cell carcinoma expressed SPRR3. CONCLUSIONS: As SPRRs were originally cloned on the basis of their expression in ultraviolet light-irradiated keratinocytes, the expression of SPRR3 in actinic lesions is of interest, and might serve as a diagnostic tool.
BACKGROUND: The formation of the cornified cell envelope (CE) during the late stages of epidermal differentiation is essential for epidermal barrier function and protects the body against environmental attack and water loss. Formation of the CE involves the replacement of the plasma membrane by cross-linkage of precursor proteins such as involucrin, small proline rich proteins (SPRR) and loricrin. In normal epidermis, SPRR1 is restricted to appendages, SPRR2 is also expressed in interfollicular areas, while SPRR3 is completely absent; the latter is most abundant in oral epithelium. This differential expression indicates an important part for SPRRs in specific barrier requirements, and reflects their importance in the biomechanical properties of the CE. OBJECTIVES: We report here on the expression of SPRR1, SPRR2 and SPRR3 in a wide range of cutaneous neoplastic and inflammatory diseases. METHODS: We used immunohistochemistry; in addition, Northern blot analysis of malignant tumours was performed. RESULTS: Increased suprabasal expression of SPRR1 and SPRR2, but no SPRR3 expression, was noted in inflammatory dermatoses with orthokeratotic and parakeratotic squamous differentiation. By contrast, differentiating epidermal tumours such as Bowen's disease, keratoacanthoma and squamous cell carcinoma expressed SPRR3. CONCLUSIONS: As SPRRs were originally cloned on the basis of their expression in ultraviolet light-irradiated keratinocytes, the expression of SPRR3 in actinic lesions is of interest, and might serve as a diagnostic tool.
Authors: Louis Tong; Rosa M Corrales; Zhuo Chen; Arturo L Villarreal; Cintia S De Paiva; Roger Beuerman; De-Quan Li; Stephen C Pflugfelder Journal: Invest Ophthalmol Vis Sci Date: 2006-05 Impact factor: 4.799
Authors: M Nacht; T Dracheva; Y Gao; T Fujii; Y Chen; A Player; V Akmaev; B Cook; M Dufault; M Zhang; W Zhang; M Guo; J Curran; S Han; D Sidransky; K Buetow; S L Madden; J Jen Journal: Proc Natl Acad Sci U S A Date: 2001-12-18 Impact factor: 11.205
Authors: V Bakthavatchalu; A Meka; S Sathishkumar; M C Lopez; R K Verma; S M Wallet; I Bhattacharyya; B F Boyce; J J Mans; R J Lamont; H V Baker; J L Ebersole; L Kesavalu Journal: Mol Oral Microbiol Date: 2010-08 Impact factor: 3.563
Authors: V Bakthavatchalu; A Meka; J J Mans; S Sathishkumar; M C Lopez; I Bhattacharyya; B F Boyce; H V Baker; R J Lamont; J L Ebersole; L Kesavalu Journal: Mol Oral Microbiol Date: 2011-07-19 Impact factor: 3.563
Authors: Marcel Oliver Schmidt; Khalid Ammar Garman; Yong Gu Lee; Chong Zuo; Patrick James Beck; Mingjun Tan; Juan Antonio Aguilar-Pimentel; Markus Ollert; Carsten Schmidt-Weber; Helmut Fuchs; Valerie Gailus-Durner; Martin Hrabe de Angelis; Elena Tassi; Anna Tate Riegel; Anton Wellstein Journal: J Invest Dermatol Date: 2017-08-31 Impact factor: 8.551
Authors: Pamela A Knight; Alan D Pemberton; Kevin A Robertson; Douglas J Roy; Steven H Wright; Hugh R P Miller Journal: Infect Immun Date: 2004-10 Impact factor: 3.441
Authors: Harold Brem; Olivera Stojadinovic; Robert F Diegelmann; Hyacinth Entero; Brian Lee; Irena Pastar; Michael Golinko; Harvey Rosenberg; Marjana Tomic-Canic Journal: Mol Med Date: 2007 Jan-Feb Impact factor: 6.354
Authors: Laura M Rogers; Jesse D Riordan; Brian L Swick; David K Meyerholz; Adam J Dupuy Journal: J Invest Dermatol Date: 2013-02-20 Impact factor: 8.551